Search

Halozyme Therapeutics Inc

Open

BrancheGesundheitswesen

72.39 1.81

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

70.13

Max

71.86

Schlüsselkennzahlen

By Trading Economics

Einkommen

292M

150M

Verkäufe

-75M

377M

KGV

Branchendurchschnitt

24.207

50.958

EPS

1.221

Gewinnspanne

39.832

Angestellte

423

EBITDA

-62M

220M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+13.84% upside

Dividenden

By Acuity

Nächstes Ergebnis

4. Aug. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

533M

8.2B

Vorheriger Eröffnungskurs

70.58

Vorheriger Schlusskurs

72.39

Nachrichtenstimmung

By Acuity

37%

63%

108 / 342 Ranking in Healthcare

Halozyme Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Juni 2026, 23:56 UTC

News
Correlated Moves

Ethereum is trading lower during Wednesday's session, reflecting broader market trends as Bitcoin also declines. The cryptocurrency remains below its 20-day moving average.

24. Juni 2026, 23:52 UTC

News
Correlated Moves
Social Media

Applied Materials shares rose in after-market trading, boosted by strong earnings from Micron Technology and positive sentiment in the semiconductor sector.

24. Juni 2026, 23:52 UTC

News
Correlated Moves

Lam Research Corp shares rise in after-market trading, driven by positive sentiment from Micron Technology's strong results and broader semiconductor sector gains.

24. Juni 2026, 23:41 UTC

News

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, following a session marked by declines and mixed global market dynamics.

24. Juni 2026, 23:41 UTC

News
Correlated Moves

Alphabet Inc. shares are lower in after-market hours, down $1.13 to about $345.00, amid a broader decline in the Interactive Media & Services sector.

24. Juni 2026, 23:41 UTC

Event
News

Trip.com Group Ltd's stock is lower in after-market trading following a first-quarter net income decline and reduced second-quarter revenue guidance.

24. Juni 2026, 23:41 UTC

ETF Constituents
News
Social Media

Invesco QQQ Trust Series I rises in after-market trading, boosted by strong Q3 earnings from Micron Technologies and positive sentiment from tech sector recovery.

24. Juni 2026, 23:41 UTC

News
Correlated Moves

Western Digital shares rose sharply in after-hours trading following strong Q3 results from Micron Technology, which beat earnings and revenue expectations.

24. Juni 2026, 23:41 UTC

Correlated Moves
News

iShares Silver Trust is trading higher in after-market hours, reflecting recovery after recent declines despite slight decreases in gold prices.

24. Juni 2026, 23:41 UTC

Correlated Moves
News

SPDR Gold Shares advance in after-market trading despite lower gold prices and a slight decline in silver. U.S. stocks show generally higher performance.

24. Juni 2026, 23:41 UTC

Correlated Moves
News
Social Media

Qualcomm shares rose after Investor Day, doubling fiscal 2029 non-handset revenue targets to $40 billion and announcing a partnership with Meta Platforms for data center CPUs.

24. Juni 2026, 23:41 UTC

News

Comcast shares are higher after reports of its subsidiary Sky acquiring ITV's Broadcast unit for about £1.6 billion, pending legal review.

24. Juni 2026, 23:36 UTC

News

Gilead Sciences' Trodelvy receives FDA approval for first-line treatment of triple-negative breast cancer, boosting shares in after-market hours.

24. Juni 2026, 23:32 UTC

News
Event
Social Media

Micron Technology reported record third-quarter revenue of $41.46 billion and strong fourth-quarter guidance, driving shares higher in after-market trading.

24. Juni 2026, 23:31 UTC

News
Social Media

United States Oil Fund LP is trading higher in after-market hours following a larger-than-expected drop in U.S. crude oil inventories for the week.

24. Juni 2026, 23:11 UTC

Correlated Moves
News
Social Media

Meta shares rise in after-market trading following a strategic partnership with Qualcomm and government discussions on AI oversight.

24. Juni 2026, 23:06 UTC

News
Social Media

Tesla Inc shares are higher in after-market trading, supported by a multi-year agreement with NatPower for battery energy storage systems in Europe.

24. Juni 2026, 23:06 UTC

Correlated Moves
News

The iShares 7-10 Year Treasury Bond ETF is trading higher in after-market hours, reflecting routine movement near its one-month trading range.

24. Juni 2026, 23:06 UTC

News
Correlated Moves
ETF Constituents

SPDR Dow Jones Industrial Average ETF Trust rises in after-market trading, aided by strong earnings from Micron Technologies and lower oil prices this week.

24. Juni 2026, 23:05 UTC

News
Correlated Moves

The Vanguard Total Bond Market ETF is higher in after-market hours, reflecting broader market recovery amid easing concerns over U.S.-Iran negotiations affecting energy supply.

24. Juni 2026, 23:02 UTC

News
ETF Constituents

The Vanguard Growth ETF is gaining in after-market trading, supported by strong performances from AMD and KLA Corporation. Oil prices have declined below $80 per barrel.

24. Juni 2026, 23:02 UTC

News
Correlated Moves

The iShares 20+ Year Treasury Bond ETF is higher in after-market trading, buoyed by U.S. Bancorp's dividend increase and positive sentiment in fixed-income securities.

24. Juni 2026, 23:02 UTC

News
ETF Constituents
Macro News

Vanguard Information Technology ETF gains after-hours, supported by Micron Technology's record earnings and strong performance from top holdings.

24. Juni 2026, 23:01 UTC

News

Charter Communications Inc. gains in after-market trading, supported by positive sentiment from the Federal Reserve's stress test results and strong mobile segment growth.

24. Juni 2026, 22:51 UTC

News

Booking Holdings Inc may benefit from falling oil prices, with WTI crude below $70 and Brent at $74, potentially boosting travel demand. Shares are roughly flat in after-market trading.

24. Juni 2026, 20:07 UTC

News

Business confidence in Germany rose, lifting the EUR/ZAR higher during Wednesday's session. The Ifo index increased to 85.6 points, surpassing expectations.

24. Juni 2026, 20:06 UTC

News
Correlated Moves

The US Dollar Index has risen, supporting higher trading in USD/DKK amid a broader trend of strength in the U.S. dollar.

24. Juni 2026, 20:06 UTC

Macro Event
News
Correlated Moves

The U.S. current account deficit widened to $226.8 billion, influencing notable volatility in the USD/CZK exchange rate, which is higher since Tuesday's close.

24. Juni 2026, 20:06 UTC

News
Correlated Moves

The US dollar's strength drives USD/SGD higher, reflecting a flight to safety amid economic and geopolitical concerns. The pair remains near its one-month trading range.

24. Juni 2026, 20:06 UTC

News
Correlated Moves

USD/SEK is trading higher as the US Dollar Index strengthens amid a flight to safety, recovering from a midday dip while above its 20-day moving average.

Peer-Vergleich

Kursveränderung

Halozyme Therapeutics Inc Prognose

Kursziel

By TipRanks

13.84% Vorteil

12-Monats-Prognose

Durchschnitt 81 USD  13.84%

Hoch 96 USD

Tief 57 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Halozyme Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

6 ratings

3

Buy

2

Halten

1

Sell

Stimmung

By Acuity

108 / 342 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Halozyme Therapeutics Inc

Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; rilpivirine, cabotegravir, and N6LS BNAB for the treatment of HIV; ocrelizumab for multiple sclerosis; XYOSTED, an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of chronic lymphocytic leukemia; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergic reactions; nivolumab+relatlimab and ANTI-TIM3 for the treatment of solid tumors; ARGX-117 for multifocal motor neuropathy; atezolizumab; nivolumab; afgartigimod; teriparatide injections; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
help-icon Live chat